NCT05239416

Brief Summary

In this study, investigators aim to use fat grafting in patients with previously healed venous ulcers to study its role on increasing skin thickness and reconstructing skin layers which was damaged by venous hypertension and determine its impact on reducing recurrence rates at 1 year

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 14, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

February 14, 2022

Status Verified

February 1, 2022

Enrollment Period

1.4 years

First QC Date

January 24, 2022

Last Update Submit

February 3, 2022

Conditions

Keywords

venous, ulcers, fat graft, adipose, stem cells

Outcome Measures

Primary Outcomes (1)

  • Patient's quality of life post fat grafting

    Chronic Lower Limb Venous Insufficiency Questionnaire - 14 (CIVIQ-14)

    1 year

Secondary Outcomes (5)

  • Skin thickness changes

    1 year

  • Recurrence rates

    1 year

  • Time to recurrence

    1 year

  • Incidence of adverse events

    1 year

  • Pain severity scores

    1 year

Study Arms (2)

Fat grafting combined with compression therapy

EXPERIMENTAL

Fat grafting + compression bandages/stockings Fat grafting: For the purposes of this study, the standard technique will be used for all patients * General or local anaesthesia. * Performed under the supervision of a plastic surgeon. * Harvest site will be either abdomen or lower limb. * After harvesting fat by liposuction, the lipoaspirate (which contains the ASCs) will be injected at the base of the healed venous ulcer within the same aseptic operative setting. Compression therapy: compression bandages / stockings as per routine practice

Procedure: Fat grafting

Compression therapy only

NO INTERVENTION

Compression therapy: compression bandages / stockings as per routine practice

Interventions

Fat graftingPROCEDURE

Under general or local anaesthesia, fat will be harvested from either abdomen or lower limb. After harvesting the fat by liposuction, the lipoaspirate will be injected underneath the healed ulcer area under complete aseptic operative setting

Fat grafting combined with compression therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or more.
  • Able to provide written informed consent.
  • Healed primary venous ulcers (C5 on CEAP classification) of 5cm or less for at least 1 month.
  • Ankle-brachial pressure index (ABPI) of 0.8 or more.

You may not qualify if:

  • Healed recurrent venous ulcers
  • Evidence of deep venous occlusion
  • Malignancy or immune-suppression
  • Malnutrition
  • Multi-organ failure
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed Elsharkawi

Galway, Ireland

RECRUITING

MeSH Terms

Conditions

Varicose UlcerUlcer

Condition Hierarchy (Ancestors)

Varicose VeinsVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mohamed Elsharkawi

    University College Hospital Galway

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohamed Elsharkawi

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mr

Study Record Dates

First Submitted

January 24, 2022

First Posted

February 14, 2022

Study Start

February 1, 2022

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

February 14, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations